SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artŪculo

TRINIDAD, J. M.  y  TORRES, L. M.. Uso del parche de capsaicina 8% para el tratamiento del dolor por infusión de treprostinil subcutáneo. Rev. Soc. Esp. Dolor [online]. 2012, vol.19, n.3, pp.134-137. ISSN 1134-8046.

    1. Ashby LK, Hague K, Latham L. Protocol for reduction of site pain in the administration of treprostinil. Chest 2004;126(4 suppl):882S. [ Links ]

    2. Barberà JA, Escribano P, Morales P, et al. Estándares asistenciales en hipertensión pulmonar. Documento de consenso elaborado por la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y la Sociedad Española de Cardiología (SEC). Joan Arch Bronconeumol. 2008;44(2):87-99. Rev Esp Cardiol 2008;61(2):170-84. [ Links ]

    3. Barst RJ, Galie N, Naeije R, et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J 2006;28:1195-203. [ Links ]

    4. Lang I, Gomez-Sanchez M, Kneussl M, et al. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest 2006;129(6): 1636-43. [ Links ]

    5. Mathier MA, McDevitt S, Saggar R. Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations. J Heart Lung Transplant 2010; 29(11):1210-7. [ Links ]

    6. Paramothayan NS, Lasserson TJ, Wells AU, Walters EH. Prostacyclin for pulmonary hypertension in adults. Cochrane Database Syst Rev 2005;(2)(2): CD002994. [ Links ]

    7. Sánchez Román J, García Hernández FJ, Castillo Palma MJ, et al. Diagnóstico y tratamiento de la hipertensión pulmonar. Rev Clin Esp 2008;208(3):142-55. [ Links ]

    8. Simonneau G, Barst RJ, Galie N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2002;165(6): 800-4. [ Links ]

    9. Skoro-Sajer N, Lang I. The role of treprostinil in the management of pulmonary hypertension. Am J Cardiovasc Drugs 2008;8(4):213-7. [ Links ]

    10. Skoro-Sajer N, Lang I, Naeije R. Treprostinil for pulmonary hypertension. Vasc Health Risk Manag 2008;4(3):507-13. [ Links ]

    11. Skoro-Sajer N, Lang IM, Harja E, et al. A clinical comparison of slow- and rapid-escalation treprostinil dosing regimens in patients with pulmonary hypertension. Clin Pharmacokinet 2008;47(9):611-8. [ Links ]

    12. Vachiery JL, Naeije R. Treprostinil for pulmonary hypertension. Expert Rev Cardiovasc Ther 2004;2(2): 183-91. [ Links ]